The short version
Only one company currently supplies this market — there is no backup if it stumbles. Historically, drugs in this position went on to a new shortage within 90 days about 0.4% of the time — roughly 3× the typical drug (0.1%).
Market view
hydroxocobalamin · Injection
1 marketed package NDCs · 1 active manufacturer
Most dispensed: ACETATE 1000 ug/mL · Injection, Solution · #1 vial, multi-dose/carton / 30 ml in 1 vial, multi-dose
Same drug class
Other molecules FDA puts in Antidote, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- acetylcysteine - ballota foetida - epinephrine - glutathione - interferon gamma-1b - lenograstim - lithium carbonate - melatonin - penicillium glabrum - potassium carbonate - pummelo - rhodotorula rubra - silver nitrate - strychnos nux-vomica seed - sus scrofa cerebral cortex - sus scrofa stomach - sus scrofa superior gastric plexus - sus scrofa thalamus -· 1 maker
- multivitamin· 2 makers
- fomepizole· 10 makers
- acetylcysteine· 24 makers
Common questions
- Is Hydroxocobalamin in shortage right now?
- Yes. FDA currently lists Hydroxocobalamin in shortage. This page is rebuilt every morning from FDA's shortage database.
- Who makes Hydroxocobalamin?
- 9 companies have marketed Hydroxocobalamin in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
- What does Hydroxocobalamin cost?
- The typical pharmacy pays about $0.8144 per mL, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.